"...has a newsletter recommended them?"
I don't know @gmac, but I can understand why an astute newsletter editor might be focussing on CTE:
1. Uncertainty about Cell Care sell-down depressing the SP now removed;
2. New substantial shareholder announcement imminent;
3. Company share-buy back scheme to start in mid-April;
4. Cash backing of $4.3m;
5. Enterprise value at a humble ~$6m;
6. No debt;
7. First half revenue up 18.5% after a 30% rise in clinical trials revenue;
8. Pivotal and unique moated exposure to the national clinical trials industry and the exploding medicinal cannabis market.
And all of this for a stock that's ~50% below its 52 week high. Conclusion: I see scope for material improvement in the SP.
- Forums
- ASX - By Stock
- Ann: Change in substantial holding
"...has a newsletter recommended them?" I don't know @gmac, but...
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CTE (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.13 |
Change
0.030(2.73%) |
Mkt cap ! $55.15M |
Open | High | Low | Value | Volume |
$1.14 | $1.14 | $1.13 | $51 | 45 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 9411 | $1.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 5907 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 9411 | 1.100 |
1 | 22000 | 0.980 |
2 | 1270 | 0.810 |
1 | 10000 | 0.795 |
1 | 2094 | 0.785 |
Price($) | Vol. | No. |
---|---|---|
1.130 | 5907 | 1 |
1.150 | 25000 | 2 |
1.180 | 650 | 1 |
1.250 | 20000 | 1 |
1.350 | 15000 | 1 |
Last trade - 15.07pm 17/06/2024 (20 minute delay) ? |
Featured News
CTE (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online